Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective.
Nutrients
; 15(8)2023 Apr 20.
Article
in En
| MEDLINE
| ID: mdl-37111211
ABSTRACT
The prevalence of Non-alcoholic fatty liver disease (NAFLD) and associated complications, such as hepatocellular carcinoma (HCC), is growing worldwide, due to the epidemics of metabolic risk factors, such as obesity and type II diabetes. Among other factors, an aberrant lipid metabolism represents a crucial step in the pathogenesis of NAFLD and the development of HCC in this population. In this review, we summarize the evidence supporting the application of translational lipidomics in NAFLD patients and NAFLD associated HCC in clinical practice.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Diabetes Mellitus, Type 2
/
Non-alcoholic Fatty Liver Disease
/
Liver Neoplasms
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Nutrients
Year:
2023
Type:
Article
Affiliation country:
United kingdom